Trexquant Investment »

Arrivent Biopharma shares owned by Trexquant Investment

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 72k 34.74

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
BlackRock
OrbiMed Advisors
FMR
Octagon Capital Advisors
Vanguard Capital Management
Sofinnova Ventures
Vivo Capital
Novo A/S
General Catalyst Group Management
State Street Corporation
Logos Global Management
Geode Capital Management

View all funds holding Arrivent Biopharma